Journal article

Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ size

TD Hewitson, C Zhao, B Wigg, SW Lee, ER Simpson, WC Boon, CS Samuel

Endocrinology | ENDOCRINE SOC | Published : 2012

Abstract

This study determined the effects of castration and hormone replacement therapy on the age-related cardiac and renal pathology of male relaxin gene-knockout (RlnKO) and age-matched wild-type (RlnWT) mice and that of aged male aromatase knockout (ArKO) mice, which lack estrogens and have 5-10 times the androgen levels of male wild-type mice. One-month-old RlnWT and RlnKO mice were bilaterally gonadectomized or sham operated and maintained until 12 months. Subgroups of castrated animals received testosterone or 17 β-estradiol treatment from 9 to 12 months. Male ArKO mice and aromatase wild-type mice were aged to 12 months. Collected heart and kidney tissues were assessed for changes in organ s..

View full abstract

University of Melbourne Researchers

Grants

Awarded by NHMRC


Funding Acknowledgements

This work was supported by a National Heart Foundation of Australia/National Health and Medical Research Council of Australia (NHMRC) R. D. Wright Fellowship (to C. S. S.), an NHMRC Senior Principal Research Fellowship (to E. R. S.), an NHMRC Project Grant (494813) (to W. C. B.), and by the Victorian Government's Operational Infrastructure Support Program.